arrow
J

John Busby

queen's university
H指数:38
被引数:5,774

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and validation of the Risk of Exacerbation in Severe Asthma (RESA) model

严重哮喘加重风险(RESA)模型的开发与验证

2026-03-270
OAAI
Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from the UK Severe Asthma Registry

生物制剂在不符合生物制剂III期随机对照试验资格的重度哮喘患者中的真实世界疗效:来自英国重度哮喘登记研究的分析

2026-01-190
PRE
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approach

对重度哮喘患者T2炎症程度梯度下生物制剂应答的研究:一种数据驱动的生物标志物聚类方法

2025-09-020
OAAI
Effects of obesity on response to asthma biologic treatment: Longitudinal data from the United Kingdom Severe Asthma Registry

肥胖对哮喘生物制剂治疗反应的影响:来自英国重症哮喘登记研究的纵向数据

2025-08-050
OAAI
Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis

真实世界中nirsevimab、RSV母体疫苗和老年人群RSV疫苗的使用情况:一项系统评价和Meta分析

2025-06-010
OA
Prediction Pathway for Severe Asthma Exacerbations

严重哮喘急性发作的预测通路

CHEST
IF8.6
2025-05-190
OA
Exploring the Long-Term Utility of Remotely Monitored FeNO Suppression Testing in Severe Asthma

探索远程监测的FeNO抑制试验在重症哮喘中的长期效用

2025-04-300
OAAI
Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data

生物制剂启动对口服糖皮质激素使用的影响:国际重症哮喘注册登记研究与国际患者护理研究数据库的真实世界数据合并分析

2025-04-260
OAAI
Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland

2004年至2023年英格兰、威尔士、苏格兰东南部和北爱尔兰地区哮喘、慢性阻塞性肺疾病和间质性肺疾病的发病率和患病率:对纵向队列的协调分析

THORAX
IF7.7
2025-04-080
PRE
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults

成人重症哮喘生物治疗后临床缓解的定义和预测因素探讨

2024-10-018
OAAI
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
2024-09-018
OAAI